U.S. Acting Attorney General Todd Blanche announced a two-phase cannabis rescheduling package on April 23, sparking no shortage of cannabis industry reactions to the immediate and forthcoming impacts.
[...]
Frank A. Segall, Chair, Blank Rome’s Cannabis Industry Group
“The Trump administration’s move on the rescheduling of cannabis is long overdue and monumental. It recognizes the importance of further legitimizing the health and wellness benefits of this miracle plant, allowing research and clinical trials to advance, and expanding access for those who may benefit from its medicinal properties.
“However, meaningful and equitable access for all Americans, and fair treatment of the industry comparable to that extended to all other businesses, will only be achieved with full rescheduling of cannabis.” -Frank A. Segall
To read the full article, please click here.
"Cannabis Industry Stakeholders React to Trump DOJ’s Rescheduling Order, New Hearing," by Tony Lange was published in Cannabis Business Times on April 23, 2026.